Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2018 Update

Summary

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research areas. Its clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. IDS offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes. The company offers application training and advice, customized training, qualified customer care centers and regionalised proximity teams. It has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Immunodiagnostic Systems Holdings plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 3
List of Figures 3
Immunodiagnostic Systems Holdings plc Company Overview 4
Immunodiagnostic Systems Holdings plc Company Snapshot 4
Immunodiagnostic Systems Holdings plc Pipeline Products and Ongoing Clinical Trials Overview 4
Immunodiagnostic Systems Holdings plc Pipeline Analysis Overview 7
Immunodiagnostic Systems Holdings plc - Key Facts 7
Immunodiagnostic Systems Holdings plc - Major Products and Services 8
Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage 9
Immunodiagnostic Systems Holdings plc Pipeline Products Overview 11
IDS-iSYS - 17-beta Estradiol Assay 11
IDS-iSYS - 17-beta Estradiol Assay Product Overview 11
IDS-iSYS - Total Testosterone Assay 12
IDS-iSYS - Total Testosterone Assay Product Overview 12
IDS-iSYS Bioactive PTH (1-84) Kit 13
IDS-iSYS Bioactive PTH (1-84) Kit Product Overview 13
IDS-iSYS Cortisol Assay 14
IDS-iSYS Cortisol Assay Product Overview 14
IDS-iSYS Free Testosterone Assay 15
IDS-iSYS Free Testosterone Assay Product Overview 15
IDS-iSYS MGP Assay 16
IDS-iSYS MGP Assay Product Overview 16
Immunodiagnostic Systems Holdings plc - Key Competitors 17
Immunodiagnostic Systems Holdings plc - Key Employees 18
Immunodiagnostic Systems Holdings plc - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Immunodiagnostic Systems Holdings plc, Recent Developments 20
Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018 20
Apr 04, 2018: Meet IDS at MEDLAB Asia Pacific 2018 from the 2 nd until the 4 th of April 23
Mar 29, 2018: Immunodiagnostic Systems Holdings: Launch of two new automated assays 23
Mar 21, 2018: Immunodiagnostic Systems Holdings: Directorate Change 2018 24
Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017 24
Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change 30
Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017 30
Aug 10, 2017: Launch of IDS-iSYS Free Testosterone assay - New Assay In The IDS Fertility Portfolio 31
Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 31
Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 32
Appendix 33
Methodology 33
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables


Immunodiagnostic Systems Holdings plc Pipeline Products and Ongoing Clinical Trials Overview 4
Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type 5
Immunodiagnostic Systems Holdings plc Pipeline Products by Indication 6
Immunodiagnostic Systems Holdings plc, Key Facts 7
Immunodiagnostic Systems Holdings plc, Major Products and Services 8
Immunodiagnostic Systems Holdings plc Number of Pipeline Products by Development Stage 9
Immunodiagnostic Systems Holdings plc Pipeline Products Summary by Development Stage 10
IDS-iSYS - 17-beta Estradiol Assay - Product Status 11
IDS-iSYS - 17-beta Estradiol Assay - Product Description 11
IDS-iSYS - Total Testosterone Assay - Product Status 12
IDS-iSYS - Total Testosterone Assay - Product Description 12
IDS-iSYS Bioactive PTH (1-84) Kit - Product Status 13
IDS-iSYS Bioactive PTH (1-84) Kit - Product Description 13
IDS-iSYS Cortisol Assay - Product Status 14
IDS-iSYS Cortisol Assay - Product Description 14
IDS-iSYS Free Testosterone Assay - Product Status 15
IDS-iSYS Free Testosterone Assay - Product Description 15
IDS-iSYS MGP Assay - Product Status 16
IDS-iSYS MGP Assay - Product Description 16
Immunodiagnostic Systems Holdings plc, Key Employees 18
Immunodiagnostic Systems Holdings plc, Subsidiaries 19
Glossary 35

List Of Figures


Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type 5
Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage 9

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2018 Update

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone

USD 750 View Report

Immunodiagnostic Systems Holdings plc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Immunodiagnostic Systems Holdings plc Company Profile is a detailed strategic and analytical report on Immunodiagnostic Systems Holdings plc. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Electro Optic Systems Holdings Ltd (EOS) - Financial and Strategic SWOT Analysis Review

Electro Optic Systems Holdings Ltd (EOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

Spirit AeroSystems Holdings, Inc. - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Spirit AeroSystems Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Spirit AeroSystems Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available